GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China’s Core Innovative Drug Assets
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets HONG KONG, Feb 6, 2026 - (ACN Newswire) – According to disclosure of interests filed with the Hong Kong Stock Exchange (HKEX), the Government of Singapore Investment Corporation (GIC) has acquired an initial…
bubmagFebruary 6, 2026